Pfizer

New Orleans

Fierce Pharma

Eli Lilly is the ‘clear winner’ from ADA, RBC analyst says

Lilly emerged as the “clear winner from ADA,” said RBC's Trung Hyunh, who added “the field is getting more crowded—but Lilly is widening its lead.”

Kevin Dunleavy Jun 8, 2026 3:12pm

Pfizer ADA

ADA: Pfizer pads case for berobenatide in obesity

Jun 6, 2026 9:29am

ASCO

Fierce Pharma

At ASCO, China biotech industry cements its coming of age

Jun 3, 2026 8:50am

SWI SNF

Foundation Medicine tallies FDA nod for latest blood test

Jun 2, 2026 10:45am

Graphic of a fork in the road with arrows pointing in either direction

ASCO: BioNTech/BMS, Pfizer split on bispecific approach in NSCLC

May 30, 2026 3:30pm

graphic image of China flags overlapping with US flags

Pfizer pens $10B, 12-drug deal with Innovent

May 29, 2026 4:05am